These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29109100)

  • 1. High Resolution Proteomic Analysis of the Cervical Cancer Cell Lines Secretome Documents Deregulation of Multiple Proteases.
    Pappa KI; Kontostathi G; Makridakis M; Lygirou V; Zoidakis J; Daskalakis G; Anagnou NP
    Cancer Genomics Proteomics; 2017; 14(6):507-521. PubMed ID: 29109100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.
    Kontostathi G; Zoidakis J; Makridakis M; Lygirou V; Mermelekas G; Papadopoulos T; Vougas K; Vlamis-Gardikas A; Drakakis P; Loutradis D; Vlahou A; Anagnou NP; Pappa KI
    Biomed Res Int; 2017; 2017():4180703. PubMed ID: 28261610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Analysis of Normal and Cancer Cervical Cell Lines Reveals Deregulation of Cytoskeleton-associated Proteins.
    Pappa KI; Lygirou V; Kontostathi G; Zoidakis J; Makridakis M; Vougas K; Daskalakis G; Polyzos A; Anagnou NP
    Cancer Genomics Proteomics; 2017; 14(4):253-266. PubMed ID: 28647699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane proteomics of cervical cancer cell lines reveal insights on the process of cervical carcinogenesis.
    Pappa KI; Christou P; Xholi A; Mermelekas G; Kontostathi G; Lygirou V; Makridakis M; Zoidakis J; Anagnou NP
    Int J Oncol; 2018 Nov; 53(5):2111-2122. PubMed ID: 30106135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution analysis of the intracellular proteome of cervical cancer cell lines unveils novel regulators of cervical carcinogenesis.
    Pappa KI; Lygirou V; Kontostathi G; Makridakis M; Vougas K; Sfakianakis A; Daskalakis G; Zoidakis J; Anagnou NP
    Oncol Rep; 2019 Oct; 42(4):1441-1450. PubMed ID: 31524267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HPV16 E6* Alters β-Integrin and Mitochondrial Dysfunction Pathways in Cervical Cancer Cells.
    Evans W; Filippova M; Filippov V; Bashkirova S; Zhang G; Reeves ME; Duerksen-Hughes P
    Cancer Genomics Proteomics; 2016; 13(4):259-73. PubMed ID: 27365376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry.
    Gu Y; Wu SL; Meyer JL; Hancock WS; Burg LJ; Linder J; Hanlon DW; Karger BL
    J Proteome Res; 2007 Nov; 6(11):4256-68. PubMed ID: 17902640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence.
    da Silva Cardeal LB; Brohem CA; Corrêa TC; Winnischofer SM; Nakano F; Boccardo E; Villa LL; Sogayar MC; Maria-Engler SS
    Biochem Cell Biol; 2006 Oct; 84(5):713-9. PubMed ID: 17167534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
    Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
    Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
    Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS
    Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preprocessing and Analysis of LC-MS-Based Proteomic Data.
    Tsai TH; Wang M; Ressom HW
    Methods Mol Biol; 2016; 1362():63-76. PubMed ID: 26519169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global and Targeted Proteomics of Prostate Cancer Cell Secretome: Combination of 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry and In Silico Selection Selected Reaction Monitoring Analysis.
    Nurdin A; Hoshi Y; Yoneyama T; Miyauchi E; Tachikawa M; Watanabe M; Terasaki T
    J Pharm Sci; 2016 Nov; 105(11):3440-3452. PubMed ID: 27665127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry.
    Wu HY; Chang YH; Chang YC; Liao PC
    J Proteome Res; 2009 Jan; 8(1):380-9. PubMed ID: 19012429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic approaches to decipher cancer cell secretome.
    Brandi J; Manfredi M; Speziali G; Gosetti F; Marengo E; Cecconi D
    Semin Cell Dev Biol; 2018 Jun; 78():93-101. PubMed ID: 28684183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-depth characterization of the secretome of mouse CNS cell lines by LC-MS/MS without prefractionation.
    Woo J; Han D; Park J; Kim SJ; Kim Y
    Proteomics; 2015 Nov; 15(21):3617-22. PubMed ID: 26227174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The secretome analysis by high-throughput proteomics and multiple reaction monitoring (MRM).
    Faça VM; Palma CS; Albuquerque D; Canchaya GN; Grassi ML; Epifânio VL; de Oliveira EB
    Methods Mol Biol; 2014; 1156():323-35. PubMed ID: 24791999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of target proteins following Drosha knockdown in cervical cancer.
    Zhou J; Cai J; Huang Z; Ding H; Wang J; Jia J; Zhao Y; Huang D; Wang Z
    Oncol Rep; 2013 Nov; 30(5):2229-37. PubMed ID: 23969986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
    Zhu D; Ye M; Zhang W
    Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.